← Company

KCEL 2023-12-31 FY — report review

Status: OK; Currency: KZT; Amounts unit: millions; Forms: ✓ ✓ ✓

Report published: Not stored for this period — set financial_report_date on the row (EDGAR filingDate, KASE change_date, or manual_catalog).

Full financial report: Report (PDF)

PDF (local): /home/ubuntu/projects/frontier/data/raw_pdfs/KCEL/2023-12-31_FY_financial-results-jan-dec-2023-eng.pdf

To recalculate statement detection and previews from the PDF, use this link The default link runs in the background: a status panel shows phase, elapsed time, rough ETA, CUDA vs CPU, and OOM hints, then loads the finished report. Heavy mode with refresh does this automatically so reverse proxies do not return 502. Add &sync=1 only for one long blocking request (not recommended). You can use ?refresh=1, ?recalc=1, ?nocache=1, or ?recompute=1 on the URL. (block in the browser until done: synchronous refresh)

Metric mapping (value → extracted evidence)

Metric values use dashboard units where applicable; evidence is the stored snippet from the PDF text layer or OCR used during extraction.

Statement pages (discovery)

Statement previews & reconstructed tables

Highlights Yellow row = matched stored evidence label; orange cell = exact number used for that metric (hover row for details). Revenue Operating profit D&A EBITDA Net profit cash debt_short debt_long Assets Equity Operating CF Investing CF

Green / amber / red bars on the label column mark subtotal rows where summed detail lines match the reported total (heuristic). The table under each reconstructed grid lists every check (Σ detail vs reported, status).

P&L

Tables and checks run on 2 of 3 PDF pages for this form (timeout budget). Raise REPORT_REVIEW_HEAVY_RECON_PAGES for more.

P&L — PDF page 13

Camelot table (pages 13, primary page 13).

#	Joined label	Line item	depreciation, amortization and im…	lessee accounting, and	is replaced by a model where…
0	Definitions	Definitions
1	EBITDA: Earnings Before Interest, Tax, Depreciation and Amortization. Equals operating income before		EBITDA: Earnings Before Interest, Tax, Depreciation and Amortization. Equals operating inc
2	depreciation, amortization and impairment losses and before income from associated companies.		depreciation, amortization and impairment losses and before income from associated companies.
3	C APEX: Capital expenditures for property, plant and equipment as well as software and licenses including	C	APEX: Capital expenditures for property, plant and equipment as well as software and licenses includ
4	investments in tangible and intangible non-current assets, but excluding goodwill and fair value adjustments		investments in tangible and intangible non-current assets, but excluding goodwill and fair value adj
5	recognized in acquisitions, and excluding the recording of assets retirement obligations.		recognized in acquisitions, and excluding the recording of assets retirement obligations.
6	I FRS 16 Leases: introduces a comprehensive model for the identification of lease arrangements and	I	FRS 16 Leases: introduces a comprehensive model for the identification of lease arrangem
7	accounting treatments for both lessors and lessees. IFRS 16 will supersede the current lease guidance		accounting treatments for both lessors and lessees. IFRS 16 will supersede the current
8	including IAS 17 Leases and the related interpretations when it becomes effective.		including IAS 17 Leases and the related interpretations when it becomes effective.
9	I FRS 16 distinguishes leases and service contracts on the basis of whether an identified asset is controlled	I	FRS 16 distinguishes leases and service contracts on the basis of whether an identified asset is con
10	by a customer. Distinctions of operating leases (off balance sheet) and finance leases (on balance sheet)		by a customer. Distinctions of operating leases (off balance sheet) and finance leases (on balance s
11	are removed for lessee accounting, and is replaced by a model where a right-of-use asset and a	are removed	for	lessee accounting, and	is replaced by a model where a right-of-use asset and a
12	corresponding liability have to be recognized for all leases by lessees (i.e. all on balance sheet) except for		corresponding liability have to be recognized for all leases by lessees (i.e. all on balance sheet)
13	short-term leases and leases of low value assets.		short-term leases and leases of low value assets.
14	T he amortization of the right-of-use asset and the accumulation of interest on a financial liability replace	T	he amortization of the right-of-use asset and the accumulation of interest on a financi
15	lease payments recognized as rental expenses in profit or loss.		lease payments recognized as rental expenses in profit or loss.

No subtotal/total rows matched the built-in patterns on this table (or fewer than two detail lines above each candidate).

P&L — PDF page 14

Camelot table (pages 14, primary page 14).

#	Joined label	Line item	Q4 2023	Q4 2022	Chg (%)	2023	2022	Chg (%)
0	KZT in millions, except per share data, 12 months 12 months	KZT in millions, except per share data,				12 months	12 months
1	Q4 2023 Q4 2022 Chg (%) Chg (%)		Q4 2023	Q4 2022	Chg (%)			Chg (%)
2	number of shares and changes 2023 2022	number of shares and changes				2023	2022
3	Revenues 60 978 54 574 11,7% 223 747 219 002 2,2%	Revenues	60 978	54 574	11,7%	223 747	219 002	2,2%
4	Income from Government subsidy 1 200 462 159,74% 3 746 2 230 67,98%	Income from Government subsidy	1 200	462	159,74%	3 746	2 230	67,98%
5	Cost of sales - 43 440 - 32 661 33,00% - 156 008 - 136 269 14,49%	Cost of sales	- 43 440	- 32 661	33,00%	- 156 008	- 136 269	14,49%
6	Gross profit 18 738 22 375 -16,25% 71 485 84 963 -15,86%	Gross profit	18 738	22 375	-16,25%	71 485	84 963	-15,86%
7	Selling and marketing expenses - 1 217 - 1 299 -6,31% - 5 401 - 2 714 99,01%	Selling and marketing expenses	- 1 217	- 1 299	-6,31%	- 5 401	- 2 714	99,01%
8	General and administrative expenses - 1 550 - 5 373 -71,15% - 8 811 - 16 260 -45,81%	General and administrative expenses	- 1 550	- 5 373	-71,15%	- 8 811	- 16 260	-45,81%
9	Impairment of assets - 2 916 - 2 879 1,29% - 5 702 - 6 264 -8,97%	Impairment of assets	- 2 916	- 2 879	1,29%	- 5 702	- 6 264	-8,97%
10	Other operating income and expenses, net 185 976 -81,05% - 623 449 -238,75%	Other operating income and expenses, net	185	976	-81,05%	- 623	449	-238,75%
11	Operating income 13 240 13 800 -4,06% 50 948 60 174 -15,33%	Operating income	13 240	13 800	-4,06%	50 948	60 174	-15,33%
12	Finance income and expenses, net - 2 887 - 421 585,75% - 7 550 - 4 920 53,46%	Finance income and expenses, net	- 2 887	- 421	585,75%	- 7 550	- 4 920	53,46%
13	Net forex gain/loss, net - 180 - 1 403 -87,17% - 1 346 - 33 3978,79%	Net forex gain/loss, net	- 180	- 1 403	-87,17%	- 1 346	- 33	3978,79%
14	Profit/loss before income tax 10 173 11 976 -15,06% 42 052 55 221 -23,85%	Profit/loss before income tax	10 173	11 976	-15,06%	42 052	55 221	-23,85%
15	Income tax expense - 846 - 4 085 -79,29% - 9 155 - 14 871 -38,44%	Income tax expense	- 846	- 4 085	-79,29%	- 9 155	- 14 871	-38,44%
16	Net income 9 327 7 891 18,20% 32 897 40 350 -18,47%	Net income	9 327	7 891	18,20%	32 897	40 350	-18,47%
17	Other comprehensive income	Other comprehensive income
18	Total comprehensive income	Total comprehensive income
19	Earnings per share (KZT), basic and diluted 46,64 39,50 18,08% 164,49 201,80 -18,49%	Earnings per share (KZT), basic and diluted	46,64	39,50	18,08%	164,49	201,80	-18,49%
20	Number of shares (thousands)	Number of shares (thousands)
21	Outstanding at period-end 200 000 200 000 200 000 200 000	Outstanding at period-end	200 000	200 000		200 000	200 000
22	Weighted average,	Weighted average,
23	200 000 200 000 200 000 200 000		200 000	200 000		200 000	200 000
24	basic and diluted	basic and diluted
25	EBITDA 27 922 20 376 37,03% 95 026 89 435 6,25%	EBITDA	27 922	20 376	37,03%	95 026	89 435	6,25%
26	EBITDA excl. non-recurring items 27 922 20 729 34,70% 95 026 90 848 4,60%	EBITDA excl. non-recurring items	27 922	20 729	34,70%	95 026	90 848	4,60%
27	- 14 789 - 7 490 97,45% - 44 470 - 30 454 46,02%		- 14 789	- 7 490	97,45%	- 44 470	- 30 454	46,02%
28	Depreciation, amortization and impairment losses	Depreciation, amortization and impairment losses
29	Operating income excl. non-recurring items 13 240 14 153 -6,45% 50 948 61 587 -17,27%	Operating income excl. non-recurring items	13 240	14 153	-6,45%	50 948	61 587	-17,27%

Subtotals vs summed lines (heuristic)

For each recognised total/subtotal row, amounts in the detected reporting column are summed over preceding detail rows until another subtotal or a lookback limit. This mirrors coarse PHP-style checks; it is not a full chart-of-accounts reconciliation.

Row	Label (trimmed)	Σ detail	Reported	|Δ|/scale	Status
6	Gross profit 18 738 22 375 -16,25% 71 485 84 963 -15,86%	73,508	71,485	0.0275	Warn (4 lines)

BS

Tables and checks run on 2 of 3 PDF pages for this form (timeout budget). Raise REPORT_REVIEW_HEAVY_RECON_PAGES for more.

BS — PDF page 14

Camelot table (pages 14, primary page 14).

#	Joined label	Line item	Q4 2023	Q4 2022	Chg (%)	2023	2022	Chg (%)
0	KZT in millions, except per share data, 12 months 12 months	KZT in millions, except per share data,				12 months	12 months
1	Q4 2023 Q4 2022 Chg (%) Chg (%)		Q4 2023	Q4 2022	Chg (%)			Chg (%)
2	number of shares and changes 2023 2022	number of shares and changes				2023	2022
3	Revenues 60 978 54 574 11,7% 223 747 219 002 2,2%	Revenues	60 978	54 574	11,7%	223 747	219 002	2,2%
4	Income from Government subsidy 1 200 462 159,74% 3 746 2 230 67,98%	Income from Government subsidy	1 200	462	159,74%	3 746	2 230	67,98%
5	Cost of sales - 43 440 - 32 661 33,00% - 156 008 - 136 269 14,49%	Cost of sales	- 43 440	- 32 661	33,00%	- 156 008	- 136 269	14,49%
6	Gross profit 18 738 22 375 -16,25% 71 485 84 963 -15,86%	Gross profit	18 738	22 375	-16,25%	71 485	84 963	-15,86%
7	Selling and marketing expenses - 1 217 - 1 299 -6,31% - 5 401 - 2 714 99,01%	Selling and marketing expenses	- 1 217	- 1 299	-6,31%	- 5 401	- 2 714	99,01%
8	General and administrative expenses - 1 550 - 5 373 -71,15% - 8 811 - 16 260 -45,81%	General and administrative expenses	- 1 550	- 5 373	-71,15%	- 8 811	- 16 260	-45,81%
9	Impairment of assets - 2 916 - 2 879 1,29% - 5 702 - 6 264 -8,97%	Impairment of assets	- 2 916	- 2 879	1,29%	- 5 702	- 6 264	-8,97%
10	Other operating income and expenses, net 185 976 -81,05% - 623 449 -238,75%	Other operating income and expenses, net	185	976	-81,05%	- 623	449	-238,75%
11	Operating income 13 240 13 800 -4,06% 50 948 60 174 -15,33%	Operating income	13 240	13 800	-4,06%	50 948	60 174	-15,33%
12	Finance income and expenses, net - 2 887 - 421 585,75% - 7 550 - 4 920 53,46%	Finance income and expenses, net	- 2 887	- 421	585,75%	- 7 550	- 4 920	53,46%
13	Net forex gain/loss, net - 180 - 1 403 -87,17% - 1 346 - 33 3978,79%	Net forex gain/loss, net	- 180	- 1 403	-87,17%	- 1 346	- 33	3978,79%
14	Profit/loss before income tax 10 173 11 976 -15,06% 42 052 55 221 -23,85%	Profit/loss before income tax	10 173	11 976	-15,06%	42 052	55 221	-23,85%
15	Income tax expense - 846 - 4 085 -79,29% - 9 155 - 14 871 -38,44%	Income tax expense	- 846	- 4 085	-79,29%	- 9 155	- 14 871	-38,44%
16	Net income 9 327 7 891 18,20% 32 897 40 350 -18,47%	Net income	9 327	7 891	18,20%	32 897	40 350	-18,47%
17	Other comprehensive income	Other comprehensive income
18	Total comprehensive income	Total comprehensive income
19	Earnings per share (KZT), basic and diluted 46,64 39,50 18,08% 164,49 201,80 -18,49%	Earnings per share (KZT), basic and diluted	46,64	39,50	18,08%	164,49	201,80	-18,49%
20	Number of shares (thousands)	Number of shares (thousands)
21	Outstanding at period-end 200 000 200 000 200 000 200 000	Outstanding at period-end	200 000	200 000		200 000	200 000
22	Weighted average,	Weighted average,
23	200 000 200 000 200 000 200 000		200 000	200 000		200 000	200 000
24	basic and diluted	basic and diluted
25	EBITDA 27 922 20 376 37,03% 95 026 89 435 6,25%	EBITDA	27 922	20 376	37,03%	95 026	89 435	6,25%
26	EBITDA excl. non-recurring items 27 922 20 729 34,70% 95 026 90 848 4,60%	EBITDA excl. non-recurring items	27 922	20 729	34,70%	95 026	90 848	4,60%
27	- 14 789 - 7 490 97,45% - 44 470 - 30 454 46,02%		- 14 789	- 7 490	97,45%	- 44 470	- 30 454	46,02%
28	Depreciation, amortization and impairment losses	Depreciation, amortization and impairment losses
29	Operating income excl. non-recurring items 13 240 14 153 -6,45% 50 948 61 587 -17,27%	Operating income excl. non-recurring items	13 240	14 153	-6,45%	50 948	61 587	-17,27%

No subtotal/total rows matched the built-in patterns on this table (or fewer than two detail lines above each candidate).

BS — PDF page 15

Camelot table (pages 15, primary page 15).

#	Joined label	Line item	Column 2	31 Dec 23	Column 4	31 Dec 22
0	KZT in millions 31 Dec 23 31 Dec 22	KZT in millions		31 Dec 23		31 Dec 22
1	Активы	Активы
2	Non-current assets	Non-current assets
3	Property, plant and equipment 156 113 97 724	Property, plant and equipment		156 113		97 724
4	Intangible assets 123 824 43 482	Intangible assets		123 824		43 482
5	Investment property 339 2 210	Investment property		339		2 210
6	Advances paid for non-current assets 176 4 104	Advances paid for non-current assets		176		4 104
7	Right to use assets 41 162 15 084	Right to use assets		41 162		15 084
8	Long-term receivables 1 523 4 345	Long-term receivables		1 523		4 345
9	Contract acquisition costs 674 558	Contract acquisition costs		674		558
10	Deferred tax assets 4 148 1 598	Deferred tax assets		4 148		1 598
11	Total non-current assets 327 959 169 105	Total non-current assets		327 959		169 105
12	Current assets	Current assets
13	Inventories 9 009 7 980	Inventories		9 009		7 980
14	Trade and other receivables 32 723 26 523	Trade and other receivables		32 723		26 523
15	Other current non-financial assets 7 826 6 897	Other current non-financial assets		7 826		6 897
16	Other current financial assets 2 167 800	Other current financial assets		2 167		800
17	Income tax advance 545 30	Income tax advance		545		30
18	Financial assets at depreciable cost − 14 833	Financial assets at depreciable cost	−			14 833
19	Cash and cash equivalents 11 031 46 248	Cash and cash equivalents		11 031		46 248
20	Total current assets 63 301 103 311	Total current assets		63 301		103 311
21	Total assets 391 260 272 416	Total assets		391 260		272 416
22	Equity and liabilities	Equity and liabilities
23	Equity	Equity
24	Share capital 33 800 33 800	Share capital		33 800		33 800
25	Additional paid-in capital 1 260 1 260	Additional paid-in capital		1 260		1 260
26	Retained earnings 136 458 103 561	Retained earnings		136 458		103 561
27	Total equity 171 518 138 621	Total equity		171 518		138 621
28	Liabilities	Liabilities
29	Long-term liabilities	Long-term liabilities
30	Long-term borrowings 77 514 41 646	Long-term borrowings		77 514		41 646
31	Long-term lease liabilities 38 261 12 514	Long-term lease liabilities		38 261		12 514
32	Government subsidies: non-current portion 14 391 8 179	Government subsidies: non-current portion		14 391		8 179
33	Long-term trade payables 7 339 −	Long-term trade payables		7 339	−
34	Asset retirement obligation 3 676 3 808	Asset retirement obligation		3 676		3 808
35	Total non-current liabilities 141 181 66 147	Total non-current liabilities		141 181		66 147
36	Short-term liabilities	Short-term liabilities
37	Short-term borrowings 7 353 5 597	Short-term borrowings		7 353		5 597
38	Short-term lease liabilities 5 296 5 323	Short-term lease liabilities		5 296		5 323
39	Government subsidies: short-term portion 3 746 3 089	Government subsidies: short-term portion		3 746		3 089
40	Short-term trade payables 40 996 34 749	Short-term trade payables		40 996		34 749
41	Financial guarantees 44 155	Financial guarantees		44		155
42	Contractual liabilities 9 861 5 645	Contractual liabilities		9 861		5 645
43	Estimated liabilities 2 062 3 685	Estimated liabilities		2 062		3 685
44	Obligations to employees 5 952 5 708	Obligations to employees		5 952		5 708
45	Tax payable, except income tax 3 251 1 611	Tax payable, except income tax		3 251		1 611
46	Income tax payable − 2 086	Income tax payable	−			2 086
47	Total short-term liabilities 78 561 67 648	Total short-term liabilities		78 561		67 648
48	Total liabilities 219 742 133 795	Total liabilities		219 742		133 795
49	Total equity and liabilities 391 260 272 416	Total equity and liabilities		391 260		272 416

Subtotals vs summed lines (heuristic)

For each recognised total/subtotal row, amounts in the detected reporting column are summed over preceding detail rows until another subtotal or a lookback limit. This mirrors coarse PHP-style checks; it is not a full chart-of-accounts reconciliation.

Row	Label (trimmed)	Σ detail	Reported	|Δ|/scale	Status
11	Total non-current assets 327 959 169 105	169,136	169,105	0.0002	OK (9 lines)
20	Total current assets 63 301 103 311	103,311	103,311	0.0000	OK (7 lines)
35	Total non-current liabilities 141 181 66 147	615,805	66,147	0.8926	Mismatch (9 lines)

CF

CF — PDF page 15

No Camelot table — OCR (v8) below.

GPU v8 OCR — page 15 (52 rows). Blank amount cells are normal for section headers and line-wrapped captions; 0 from OCR on those rows is not a reported financial zero. Amounts follow the PDF header (often thousands of currency).

#	Joined label	Column 2	Column 3
0	Q4 January December 2023
1	Condensed Consolidated Statement of Financial
2	Position
3	AKTMBbI
4	Non-current assets
5	Property, plant and equipment	156113	97724
6	Intangible assets	123824	43482
7	Investment property	339	2210
8	Advances paid for non-current assets	176	4104
9	Right to use assets	41162	15084
10	Long-term receivables	1523	4345
11	Contract acquisition costs	674	558
12	Deferred tax assets	4148	598
13	Total non-current assets	327959	169105
14	Current assets
15	Inventories	9009	7980
16	Trade and other receivables	32723	26523
17	Other current non-financial assets	7826	6897
18	Other current financial assets	2167	800
19	Income tax advance	545	30
20	Financial assets at depreciable cost		14833
21	Cash and cash equivalents	11031	46248
22	Total current assets	63301	103311
23	Total assets	391260	272416
24	Equity and liabilities
25	Equity
26	Share capital	33800	33800
27	Additional paid-in capital	1260	260
28	Retained earnings	136458	103561
29	Total equity	171518	138621
30	Liabilities
31	Long-term liabilities
32	Long-term borrowings	77514	41646
33	Long-term lease liabilities	38261	12514
34	Government subsidies: non-current portion	14391	8179
35	Long-term trade payables	7339	0
36	Asset retirement obligation	3676	3808
37	Total non-current liabilities	141181	66147
38	Short-term liabilities
39	Short-term borrowings	7353	5597
40	Short-term lease liabilities	5296	5323
41	Government subsidies: short-term portion	3746	3089
42	Short-term trade payables	40996	34749
43	Financial guarantees	44	155
44	Contractual liabilities	9861	5645
45	Estimated liabilities	2062	3685
46	Obligations to employees	5952	5708
47	Tax payable, except income tax	3251	1611
48	Income tax payable	0	2086
49	Total short-term liabilities	78561	67648
50	Total liabilities	219742	133795
51	Total equity and liabilities	391260	272416

CF — PDF page 16

Camelot table (pages 16, primary page 16).

#	Joined label	Line item	Q4 2023	Q4 2022	2023	2022
0	C ondensed Consolidated Statement of Cash Flows	C	ondensed Consolidated Statement of Cash Flows
1	12 months 12 months				12 months	12 months
2	KZT in millions Q4 2023 Q4 2022	KZT in millions	Q4 2023	Q4 2022
3	2023 2022				2023	2022
4	Cash flow before change in working capital 29 584 24 001 97 672 95 154	Cash flow before change in working capital	29 584	24 001	97 672	95 154
5	Change in working capital (3 532) (4 481) (17 435) (29 226)	Change in working capital	(3 532)	(4 481)	(17 435)	(29 226)
6	Cash flow from operating activities 26 054 19 520 80 237 65 928	Cash flow from operating activities	26 054	19 520	80 237	65 928
7	Cash CAPEX (19 219) -6 226 (159 964) -37 650	Cash CAPEX	(19 219)	-6 226	(159 964)	-37 650
8	Free cash flow 6 703 13 294 (79 857) 28 278	Free cash flow	6 703	13 294	(79 857)	28 278
9	Proceeds from financial assets (net) - -14 813 14 813 -14 813	Proceeds from financial assets (net)	-	-14 813	14 813	-14 813
10	Cash flow from financing activities 102 -1 603 30 652 -18 370	Cash flow from financing activities	102	-1 603	30 652	-18 370
11	Cash flow for the period 6 937 -3 122 (34 262) -4 905	Cash flow for the period	6 937	-3 122	(34 262)	-4 905
12	Cash and cash equivalents, opening balance 4 169 51 376 46 248 51 402	Cash and cash equivalents, opening balance	4 169	51 376	46 248	51 402
13	Cash flow for the period 6 937 -3 122 (34 262) -4 905	Cash flow for the period	6 937	-3 122	(34 262)	-4 905
14	Exchange rate difference (75) -2 006 (955) -249	Exchange rate difference	(75)	-2 006	(955)	-249
15	Cash and cash equivalents, closing balance 11 031 46 248 11 031 46 248	Cash and cash equivalents, closing balance	11 031	46 248	11 031	46 248

No subtotal/total rows matched the built-in patterns on this table (or fewer than two detail lines above each candidate).

Formulas used

• Net debt: debt_short + debt_long + other_financial_liabilities + non_controlling_interest − cash (mln); debt_short + debt_long + other_financial_liabilities + non_controlling_interest − cash (from row components)
• EBITDA: computed as operating_profit + da